4//SEC Filing
D'Souza Rupert 4
Accession 0001209191-22-029847
CIK 0001501756other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 6:28 PM ET
Size
7.0 KB
Accession
0001209191-22-029847
Insider Transaction Report
Form 4
D'Souza Rupert
Chief Financial Officer
Transactions
- Purchase
Common Stock
2022-05-13$0.86/sh+10,000$8,585→ 10,850 total - Purchase
Common Stock
2022-05-17$0.83/sh+10,000$8,272→ 20,850 total
Footnotes (2)
- [F1]Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $0.856 to $0.865. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $0.8245 to $0.828. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Documents
Issuer
Adverum Biotechnologies, Inc.
CIK 0001501756
Entity typeother
Related Parties
1- filerCIK 0001897112
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 6:28 PM ET
- Size
- 7.0 KB